A Phase IIB Randomized, Placebo-Controlled Trial of Pioglitazone for Oral Pre-Malignant Lesions: An Inter-Consortium Collaborative Study

Grant

Total Award Amount

  • 79481.00
  • Direct Costs

  • 61395.00
  • Sponsor Award Id

  • 949N815
  • Contributor

  • Craig Elmets M.D.   Principal Investigator